Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Beasley

Showing results (141-150 of 443) with videos related to

Pageof 45
Sort By:
Lancet (London, England)|March 29, 2026
Unanswered questions regarding the AIR strategy in children - Authors' replyLee Hatter, Karen Oldfield, Mark Weatherall, et al.
Chest|October 16, 2010
The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical studyMeme Wijesinghe, Mathew Williams, Kyle Perrin, et al.
Journal of the Royal Society of Medicine|November 2, 2010
Prolonged work- and computer-related seated immobility and risk of venous thromboembolismBridget Healy, Erik Levin, Kyle Perrin, et al.
Internal Medicine Journal|February 8, 2018
Starting beta-blockers during exacerbations of chronic obstructive pulmonary diseaseRobert J Hancox, Catherina L Chang, Richard Beasley, et al.
Respiratory Medicine|April 13, 2005
The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhalerMatthew Masoli, Mark Weatherall, Joanne Ayling, et al.
Respirology (Carlton, Vic.)|February 5, 2005
Metered dose inhalers: a need for dose countersShaun Holt, Avrille Holt, Mark Weatherall, et al.
The Lancet. Child & Adolescent Health|October 25, 2021
Respiratory syncytial virus: paying the immunity debt with interestLee Hatter, Allie Eathorne, Thomas Hills, et al.
Chest|April 8, 2009
International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillanceMeme Wijesinghe, Mark Weatherall, Kyle Perrin, et al.
Journal of the Royal Society of Medicine|May 9, 2008
A case-control study of seated immobility at work as a risk factor for venous thromboembolismJill West, Kyle Perrin, Sarah Aldington, et al.
The New Zealand Medical Journal|March 22, 2005
COX-2 inhibitors--first, do no harmMark Weatherall, Sarah Aldington, Philippa Shirtcliffe, et al.
Pageof 45

Showing results (141-150 of 443) with videos related to

Sort By:
Pageof 45
Lancet (London, England)|March 29, 2026
Unanswered questions regarding the AIR strategy in children - Authors' replyLee Hatter, Karen Oldfield, Mark Weatherall, et al.
Chest|October 16, 2010
The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical studyMeme Wijesinghe, Mathew Williams, Kyle Perrin, et al.
Journal of the Royal Society of Medicine|November 2, 2010
Prolonged work- and computer-related seated immobility and risk of venous thromboembolismBridget Healy, Erik Levin, Kyle Perrin, et al.
Internal Medicine Journal|February 8, 2018
Starting beta-blockers during exacerbations of chronic obstructive pulmonary diseaseRobert J Hancox, Catherina L Chang, Richard Beasley, et al.
Respiratory Medicine|April 13, 2005
The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhalerMatthew Masoli, Mark Weatherall, Joanne Ayling, et al.
Respirology (Carlton, Vic.)|February 5, 2005
Metered dose inhalers: a need for dose countersShaun Holt, Avrille Holt, Mark Weatherall, et al.
The Lancet. Child & Adolescent Health|October 25, 2021
Respiratory syncytial virus: paying the immunity debt with interestLee Hatter, Allie Eathorne, Thomas Hills, et al.
Chest|April 8, 2009
International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillanceMeme Wijesinghe, Mark Weatherall, Kyle Perrin, et al.
Journal of the Royal Society of Medicine|May 9, 2008
A case-control study of seated immobility at work as a risk factor for venous thromboembolismJill West, Kyle Perrin, Sarah Aldington, et al.
The New Zealand Medical Journal|March 22, 2005
COX-2 inhibitors--first, do no harmMark Weatherall, Sarah Aldington, Philippa Shirtcliffe, et al.
Pageof 45